Physician profile
German Mikheyev
NPI 1073993077
$25,306.65
in general payments reported to CMS, 2019-2025
36 companies · $4,181 in 2025
The $4,181 reported for 2025 was more than what 95% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,084 · 2020: $1,273 · 2021: $4,606 · 2022: $3,529 · 2023: $2,867 · 2024: $1,766 · 2025: $4,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,259 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Travel and Lodging: $2,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,258.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Travel and Lodging | $2,055.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,542.17 | 2019-2025 | Prostep, Infinity, Actishield |
| Arthrex, INC. | $8,024.61 | 2019-2025 | |
| Reel Surgical, INC. | $2,371.93 | 2020-2024 | |
| Treace Medical Concepts, INC. | $1,034.31 | 2021-2025 | |
| Smith+Nephew, INC. | $881.21 | 2019-2025 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| In2bones USA, LLC | $810.64 | 2019-2022 | |
| Dne LLC | $436.78 | 2019 | |
| Paragon 28, INC. | $397.25 | 2019-2022 | |
| Sanara Medtech INC. | $338.13 | 2020-2022 | |
| Next Science LLC | $292.51 | 2023 | Xperience, Surgx, Blastx |
| Linvatec Corporation | $279.86 | 2023-2025 | Allograft Tissue, Biobrace 23mm, Neospan |
| Depuy Synthes Sales INC. | $249.02 | 2021-2022 | |
| Horizon Therapeutics Plc | $211.66 | 2019-2021 | |
| Trilliant Surgical LLC. | $206.62 | 2019 | |
| Integra Lifesciences Corporation | $169.86 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $168.49 | 2021-2025 | Nuzyra |
| Axogen | $137.41 | 2020-2021 | |
| Anika Therapeutics, INC. | $113.91 | 2021 | |
| Stability Biologics, LLC | $112.83 | 2022 | |
| Osiris Therapeutics INC. | $110.00 | 2019 | |
| Kerecis Limited | $69.29 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Averitas Pharma INC. | $49.18 | 2025 | Qutenza |
| Lifenet Health | $34.93 | 2024 | Theragenesis Wound Matrix |
| Globus Medical, INC. | $26.51 | 2025 | Senza |
| Bioventus LLC | $26.11 | 2021 | |
| Abbvie INC. | $25.15 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $23.37 | 2025 | Exparel |
| Medtronic, INC. | $23.36 | 2025 | Intellis Adaptivestim |
| Zyla Life Sciences, INC. | $22.78 | 2020 | |
| Aroa Biosurgery Incorporated | $21.88 | 2025 | |
| Ascendis Pharma Endocrinology INC | $19.82 | 2025 | Yorvipath |
| Abbott Laboratories | $19.61 | 2024 | Proclaim |
| Embody, INC. | $16.97 | 2021 | |
| Amgen INC. | $14.44 | 2025 | Krystexxa |
| Organogenesis INC. | $12.70 | 2023 | Puraply |
| Nalu Medical, INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw German Mikheyev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.